Reference
Qu F, et al. An elderly advanced non-small cell lung cancer patient harboring rare epidermal growth factor receptor mutations L861R benefited from afatinib: A case report. Medicine 100: E27614, No. 45, 12 Nov 2021. Available from: URL: https://journals.lww.com/md-journal/pages/default.aspx
Rights and permissions
About this article
Cite this article
Afatinib/bevacizumab/osimertinib. Reactions Weekly 1940, 20 (2023). https://doi.org/10.1007/s40278-023-31878-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-31878-0